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Abstract
Background: Increased arterial stiffness is associated with mortality in patients with chronic
kidney disease. Cardiovascular magnetic resonance (CMR) permits assessment of the central
arteries to measure aortic function.
Methods: We studied the relationship between central haemodynamics and outcome using CMR
in 144 chronic kidney disease patients with estimated glomerular filtration rate <15 ml/min (110 on
dialysis). Aortic distensibilty and volumetric arterial strain were calculated from cross sectional
aortic volume and pulse pressure measured during the scan.
Results: Median follow up after the scan was 24 months. There were no significant differences in
aortic distensibilty or aortic volumetric arterial strain between pre-dialysis and dialysis patients.
Aortic distensibilty and volumetric arterial strain negatively correlated with age. Aortic distensibilty
and volumetric arterial strain were lower in diabetics, patients with ischaemic heart disease and
peripheral vascular disease. During follow up there were 20 deaths. Patients who died had lower
aortic distensibilty than survivors. In a survival analysis, diabetes, systolic blood pressure and aortic
distensibilty were independent predictors of mortality. There were 12 non-fatal cardiovascular
events during follow up. Analysing the combined end point of death or a vascular event, diabetes,
aortic distensibilty and volumetric arterial strain were predictors of events.
Conclusion: Deranged vascular function measured with CMR correlates with cardiovascular risk
factors and predicts outcome. CMR measures of vascular function are potential targets for
interventions to reduce cardiovascular risk.
Introduction
Premature cardiovascular disease is the leading cause of
death in patients with end stage renal disease (ESRD)
treated with dialysis. The relationship between cardiovas-
cular (CV) risk factors and CV events is less clear in ESRD
than in the general population, with paradoxical relation-
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ships between both cholesterol and blood pressure and
CV risk[1,2]. The presence of increased arterial stiffness is
a predictor of CV morbidity and mortality in ESRD[3,4].
Conventionally, this has been assessed by measurement
of pulse wave velocity (PWV). More recently, cardiovascu-
lar magnetic resonance (CMR) has been used to identify
tissue abnormalities in the heart of ESRD patients[5]. This
imaging modality also permits contemporaneous visuali-
sation of large arteries and direct measurement of aortic
function, providing an integrated assessment of both ven-
tricular and vascular function in one examination. Aortic
distensibilty (AD), the relative change in aortic size
throughout the cardiac cycle relative to blood pressure, is
readily assessed with CMR. Given the strong relationship
between vascular stiffness and outcome in ESRD, CMR
measures of vascular function may identify patients at
increased CV risk. We have demonstrated in a previous
pilot study using CMR that aortic stiffness is increased in
patients with ESRD[6]. More recently aortic stiffness has
been demonstrated with CMR to be increased in patients
with even mild chronic kidney disease (CKD), equivalent
to findings in patients with heart failure with preserved
systolic function[7].
To date however, the relationship between aortic distensi-
bilty (AD), as measured with CMR and long term out-
come has not been assessed. Thus, we assessed the
relationship between CMR measures of vascular function
and conventional CV risk factors in ESRD patients and
studied the long term prognostic implications of CMR
measures of vascular function.
Methods
Subjects
Studies were performed on 144 patients with chronic kid-
ney disease (CKD) stage 5[8]. All patients were assessed as
part of a CV screening program for renal transplantation
and therefore were either on dialysis therapy or expected
to start dialysis within six months. All patients gave writ-
ten, informed consent and the study was approved by the
local ethics committee.
CMR technique
CMR was performed using a 1.5 Tesla MR scanner
(Sonata, Siemens, Erlangen, Germany). In haemodialysis
patients imaging was performed on the post-dialysis day
whereas peritoneal dialysis patients were studied at their
"dry weight". Aortic volume was acquired from cine CMR
images in the transverse plane of the ascending aorta,
obtained at the level of the main pulmonary artery, using
a steady-state free precession (true FISP) sequence, TR =
3.2 ms, TE = 1.6 ms, FA = 60°, FoV 276 × 340 mm, pixel
dimensions 2.3 × 1.3 mm, slice thickness = 7 mm (Figure
1). The approximately 10 second breath-hold CMR
resulted in images with a temporal resolution of 22.5 ms.
During AD measurement brachial blood pressure was
measured using an oscillometric device (Schiller Mag-
screen, Schiller AG, Baar, Switzerland).
Left ventricular (LV) mass and function were measured
using a true FISP sequence to acquire cine images in long
axis planes (vertical long axis, horizontal long axis, LV
outflow tract) followed by sequential short axis LV cine
loops (8 mm slice thickness, 2 mm gap between slices)
from the atrio-ventricular ring to the apex. LV mass index
(LVMI) was calculated by normalising LV mass to the
body surface area. Overall, scan time was approximately
30 minutes.
All CMR analyses were performed using conventional
analysis software (Argus, Siemens, Erlangen, Germany).
Cross sectional aortic contours were defined by manual
planimetry throughout the cardiac cycle, with resulting
aortic volume defined as the measured cross sectional area
multiplied by the slice thickness. This calculation was per-
formed automatically by the analysis program.
Measurement of aortic distensibilty and volumetric 
arterial strain
Aortic distensibilty (AD) was calculated from change in
aortic volume and simultaneous brachial blood pressure
using the formula:
where (Aortic volume)max and (Aortic volume)min are the
maximal and minimal calculated aortic volumes during
the cardiac cycle. Additionally, aortic volumetric arterial
strain (VAS), which is non-pressure dependent, was calcu-
lated from the formula:
As a ratio of change in aortic volume, VAS does not have
any units.
Clinical data
All patients underwent conventional cardiovascular risk
factor assessment including history, clinical examination,
ECG as well as routine haematology, biochemical, and
lipid profile. A history of ischaemic heart disease (IHD)
was defined as previous clinically documented myocar-
dial infarction/angina pectoris or previous coronary revas-
cularisation procedure. Peripheral vascular disease was
defined by clinically documented intermittent claudica-
tion with prior consultation by a vascular surgeon or the
need for a previous peripheral vessel revascularisation
procedure. Blood was drawn at the time of scanning for
Aortic distensibilty
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lipids and C – reactive protein, with other haematological
and biochemical parameters (haemoglobin, dialysis ade-
quacy, calcium-phosphate product) assessed from the
mean of readings taken on the three consecutive months
preceding the scan.
Follow up
Follow up data was collected from date of the CMR scan
using electronic patient records. Death and cardiovascular
events (myocardial infarction, cerebrovascular event, cor-
onary revascularisation and amputation for peripheral
vascular disease) were collected as end points.
Statistical methods
Correlations between cardiac dimensions, measures of
arterial function and continuous clinical variables were
assessed with Pearson and Spearman co-efficients. Differ-
ences between groups were tested by student's t-test and
Mann-Whitney-U test. Measures of vascular function were
compared between patients who died or had a vascular
event during the follow up period with these measures
divided into tertiles or quartiles and subjected to an unad-
justed survival analysis by the Kaplan-Meier method. Sta-
tistical significance was determined by the log-rank test.
Cox survival analysis was performed to assess the influ-
ence of multiple variables on outcome. Variables identi-
fied as possibly influential on outcome by univariate
analysis were then entered into a forward stepwise regres-
sion model. As exponential values logarithmic transfor-
mation was used for AD and VAS values to simplify
interpretation of values in the regression analyses. Analy-
ses were performed using SPSS 13.0 software package
(SPSS Inc., Chicago, IL., USA).
Results
Subjects
Patient demographics at the time of scan are shown in
Table 1. 144 patients had aortic VAS measurement and
122 patients had measurement of AD available for analy-
sis. 22 patients did not have blood pressure readings to
calculate AD (either due to bilateral arteriovenous fistulae
used as vascular access for dialysis making recording
impossible, or due to blood pressure being recorded non-
synchronously with the AD trace).
Clinical correlates of aortic distensibilty and volumetric 
arterial strain
All scans were analysed by a single observer (P.B.M). No
significant differences in patient demographics or vascular
function were exhibited between patients with advanced
renal failure not yet on dialysis therapy (34 patients;
24.6%) and those established on dialysis (110 patients)
Representative images demonstrating sagittal view (left) used to plan transverse plane aortic images (right) with schematic trac- ing of ascending aorta (AA) Figure 1
Representative images demonstrating sagittal view (left) used to plan transverse plane aortic images (right) 
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and therefore patients were combined as a single group.
AD and VAS demonstrated a negative correlation with age
(AD R = -0.44, p < 0.001, VAS R = -0.44, p < 0.001).
There were no significant correlations between haemo-
globin, dialysis adequacy (urea reduction ratio in haemo-
dialysis or creatinine clearance in peritoneal dialysis),
time on dialysis, lipid parameters, C-reactive protein, cal-
cium, phosphate or calcium phosphate product and AD
or VAS. There were no significant differences in AD or VAS
between genders. AD and VAS were reduced in patients
with diabetes mellitus (diabetics – median AD 1.8 × 10-3
vs. non-diabetics 2.8 × 10-3 mmHg-1, p = 0.001; VAS 0.11
vs. 0.15, p = 0.001), patients with a history of ischaemic
heart disease (median AD 1.8 × 10-3 vs. 2.6 × 10-3 mmHg-
1, p = 0.028; VAS 0.11 vs. 0.15, p = 0.009) or peripheral
vascular disease (median aortic distensibilty 1.2 × 10-3 vs.
1.8 × 10-3 mmHg-1, p = 0.005; VAS 0.14 vs. 0.07, p =
0.015). No significant differences in AD or VAS were dem-
onstrated between patients treated with statins or requir-
ing antihypertensive therapy. There were no significant
differences between AD between dialysis modalities. 58
patients (40.3%) had a functioning arteriovenous fistula
or graft at the time of scanning. There were no significant
differences in AD or VAS between patients with an arteri-
ovenous fistula or graft and those without.
Weak but statistically significant negative correlations
were demonstrated between AD and LVMI (R = -0.21, p =
0.021) and end systolic volume (R = -0.18, p = 0.048) but
no other LV dimension. Aortic VAS correlated with mark-
ers of cardiac function – left ventricular ejection fraction
(R = 0.23, p = 0.006) and stroke volume (0.19, p = 0.024).
Relationship between CMR measures of vascular function 
on survival and combined mortality and cardiovascular 
events
Follow up data were available for all 144 patients. Overall
survival data was analysed for the whole cohort including
analyses of the relationship between VAS and outcome.
For analyses of the relationship between AD and out-
come, only the 120 patients who only results of AD avail-
able were studied. The median follow up period was 719
days (interquartile range 375 days). There were 20 deaths,
giving an overall mean death rate of 76.2 per 1000 patient
years. Patients who died had significantly lower AD than
those who where alive at the end of follow up. There were
no significant differences in VAS between survivors and
patients who died. Patients who died had significantly
higher systolic and pulse pressure than survivors (Figures
2, 3), but there were no significant differences in diastolic
blood pressure (Table 2).
During the follow up period there were an additional 12
non-fatal CV events (five patients had a myocardial infarc-
tion; four patients underwent coronary revascularisation,
two patients undergoing amputation for peripheral vascu-
lar disease and one patient had a cerebrovascular event).
These patients had significantly lower AD and VAS than
those who remained event free (median AD in patients
with CV events 1.5 × 10-3 vs. 2.8 × 10-3 mmHg-1, p =
0.006; VAS 0.12 vs. 0.14, p = 0.012; Figure 4). There were
no significant difference in blood pressure between
Kaplan-Meier survival curves for all cause mortality with  patients stratified by systolic blood pressure tertile Figure 2
Kaplan-Meier survival curves for all cause mortality 
with patients stratified by systolic blood pressure ter-
tile.
Table 1: Background demographics of patients studied
Number 144
Age 51.5 (11.2)
Male (%) 90 (62.5)
Height (m) 169.5 (9.8)
Weight (kg) 75.9 (16.1)
On dialysis (%) 110 (76.4)
Haemodialysis 61 (42.4)
Peritoneal dialysis 49 (34.0)
RRT time (months) 6.0 (42.0)
Past history of IHD (%) 24 (16.7)
Diabetes (%) 46 (31.9)
Smoker (%)
Never 83 (57.6)
Current 38 (26.4)
Ex 23 (16.0)
SBP (mmHg) 140.2 (24.2)
DBP (mmHg) 82.9 (12.8)
Cross sectional aortic volume (mL) 5.0 (2.0)
Aortic distensibilty (x 10-3 mmHg-1) 2.4 (2.0)
Aortic volumetric arterial strain 0.13 (0.09)
Results are show as mean with standard deviation in parenthesis or 
number with percentage in parenthesis as appropriate, except for 
RRT time and measures of vascular function which are displayed as 
median and inter quartile range.Journal of Cardiovascular Magnetic Resonance 2008, 10:39 http://www.jcmr-online.com/content/10/1/39
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patients who remained event free and patients who had a
non fatal CV event.
Combining death with non fatal CV events as a combined
CV end point, patients who reached this combined end
point had significantly lower AD (median AD 1.7 × 10-3
vs. 2.7 × 10-3 mmHg-1, p < 0.001), VAS (0.12 vs. 0.14, p =
0.006) and higher systolic blood pressure (mean 152.9 vs.
136.5 mmHg, p = 0.001) and pulse pressure (mean 67.0
vs. 54.5 mmHg, p = 0.001) than those who did not. There
were no significant differences in diastolic blood pressure
(mean 85.9 vs. 82.0 mmHg, p = 0.154) between those
who reached the combined end point and those who did
not.
In a Cox forward stepwise regression model assessing
patient survival; diabetes, systolic blood pressure and AD
were significant independent predictors of patient sur-
vival (Table 3). In a similar analysis assessing the com-
bined CV end point of death or a vascular event; diabetes,
AD and aortic VAS were significant predictors of events
(Table 4). Due to their close interdependence, blood pres-
sure variables and AD were entered individually into the
each model to determine their influence. Similarly either
AD or VAS was entered individually to the model but not
together.
Discussion
This is the first study to examine the relationship between
AD assessed with CMR and outcome in ESRD. Patients
with ESRD have previously been demonstrated to have
increased aortic stiffness compared to controls, repre-
sented by reduced AD and VAS with associated vessel dil-
atation[6]. In keeping with the relationship between
arteriosclerosis and advancing age, there was a significant
relationship between reduced AD and VAS and age. AD
and VAS were both lower in patients at highest CV risk, i.e.
those with diabetes, ischaemic heart disease and/or
peripheral vascular disease. No other factors such as drug
therapy, adequacy of dialysis, duration of renal replace-
ment therapy, dialysis modality or any laboratory param-
eter appeared to be significantly associated with AD or
VAS.
Table 2: Demographic data for patients who were alive and dead at the end of the follow up period
Alive Dead p value
Number 124 (86.1) 20 (13.9)
Age 51.5 (11.3) 51.9 (11.1) 0.876
Male (%) 80 (64.5) 10 (50.0) 0.213
On dialysis (%) 92 (74.2) 18 (90.0) 0.122
RRT time (months) 6.0 (26.0) 36.0 (107.0) 0.023
Past history of IHD (%) 19 (15.3) 5 (25.0) 0.281
Diabetes (%) 34 (27.4) 12 (60.0) 0.004
Smoker (%)
Never 73 (58.9) 10 (50.0)
Current 30 (24.2) 8 (40.0) 0.304
Ex 21 (16.9) 2 (10.0)
SBP (mmHg) 137.3 (23.6) 156.3 (21.4) 0.001
DBP (mmHg) 82.1 (12.9) 87.4 (11.7) 0.092
PP (mmHg) 55.20 (17.1) 69.0 (17.1) 0.001
Cross sectional aortic volume (mL) 5.0 (1.9) 5.1 (2.3) 0.634
Aortic distensibilty (x 10-3 mmHg-1) 2.4 (2.0) 2.1 (2.1) 0.009
Aortic volumetric arterial strain 0.12 (0.09) 0.15 (0.10) 0.176
Results are show as mean with standard deviation in parenthesis or number with percentage in parenthesis as appropriate except for RRT time and 
measures of vascular function which are displayed as median and inter quartile range. Tests of significance are t-test and Chi-squared between 
groups, except for measures of vascular function where Mann-Whitney-U was used.
Kaplan-Meier survival curves for all cause mortality with  patients stratified by aortic distensibilty tertile Figure 3
Kaplan-Meier survival curves for all cause mortality 
with patients stratified by aortic distensibilty tertile.Journal of Cardiovascular Magnetic Resonance 2008, 10:39 http://www.jcmr-online.com/content/10/1/39
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One major potential limitation of our study is that calcu-
lation of AD is based on cross-sectional volume of the ves-
sel wall and pulse pressure. For practical reasons, direct
aortic blood pressure measurement has been substituted
by non-invasive indirect brachial blood pressure. Brachial
blood pressure is not entirely representative of central
haemodynamics and our methods do not permit assess-
ment of the phenomenon of central to peripheral systolic
and pulse pressure amplification, as can be measured with
tonometry. It is difficult to dissociate any clinical effect
associated with changes in AD from that due directly to
pulse pressure, which is a well described predictor of out-
come in ESRD. Nonetheless, as it is otherwise impossible
to assess aortic stiffness without documentation of pres-
sure within the vessel lumen, the approach used in this
study has been used widely[7,9-11]. For this reason, aortic
VAS, the fractional increase in aortic volume during the
cardiac cycle was also used. This does not depend on
blood pressure variables and in this study displayed simi-
lar relationships with clinical variables and outcome.
However, there is limited literature to support its use.
Other studies have demonstrated that PWV can be meas-
ured with CMR. There are advantages to using measuring
PWV compared to AD as it is load-independent, negating
the necessity for blood pressure measurements. However,
at the time of initiation of this study, there were few stud-
ies in any patient group other than healthy volun-
teers[10,12], and unfortunately CMR derived PWV was
not measured in this study cohort.
The relationship between these markers of aortic function
and LV dimensions show a weak but significant relation-
ship between increased aortic stiffness and increasing
LVMI and end systolic volume, suggesting that reduced
AD may increase LV wall tension and hence cardiac hyper-
trophy. Aortic VAS, which is independent of blood pres-
sure, correlated with markers of systolic function, namely
ejection function and stroke volume, suggesting that in
the failing heart where systolic blood pressure is lower,
increased arterial stiffness remains deleterious to ventricu-
lar performance.
A variety of studies have addressed the role of AD as a
marker of either CV risk or relating AD to cardiac perform-
ance in other groups at high risk of CV disease. Data relat-
ing CMR measures of arterial function to long term
outcome are scarce. In otherwise healthy individuals,
obese subjects have been shown by CMR to have
increased aortic cross sectional area and decreased aortic
elasticity[13,14]. AD is reduced in patients with heart fail-
ure and correlates with exercise capacity[9]. One study in
hypertensive patients has demonstrated that AD increases
following treatment with nicardipine or alacepril but not
trichlormethiazide, independent of changes in pulse pres-
sure[15]. More recently, in patients with non diabetic
CKD, AD has been shown to correlate with GFR demon-
strating that CMR can quantify the impact of reduced kid-
ney function on vascular function in early CKD[7].
Table 3: Patient survival
Univariate analysis Multivariate analysis
Variable HR (95.0% CI) p HR (95.0% CI) p
Diabetes 3.031 (1.036, 8.866) 0.043 4.214 (1.631, 10.886) 0.003
SBP (mmHg) 1.015 (0.992, 1.038) 0.197 1.022 (1.000, 1.044) 0.049
Log aortic distensibilty 0.072 (0.008, 0.694) 0.023 0.135 (0.019, 0.948) 0.044
Log aortic VAS 0.107 (0.007, 1.732) 0.116
Duration RRT (days) 1.000 (1.000, 1.000) 0.421
Age (years) 1.015 (0.969, 1.063) 0.526
Gender (ref male) 0.833 (0.312, 2.226) 0.716
Haemoglobin (g/dL) 0.910 (0.670, 1.236) 0.547
Albumin (g/L) 0.942 (0.839, 1.058) 0.311
Cox survival analysis for patient survival. Because of their close correlation SBP aortic distensibilty and aortic VAS were entered separately into the 
model. Results for other variables are shown with systolic blood pressure in the model
Kaplan-Meier survival curves for survival to either CV end  point or death with patients stratified by aortic VAS quartile Figure 4
Kaplan-Meier survival curves for survival to either 
CV end point or death with patients stratified by aor-
tic VAS quartile.Journal of Cardiovascular Magnetic Resonance 2008, 10:39 http://www.jcmr-online.com/content/10/1/39
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Additionally, endothelial function can be studied using
CMR to by assessing cross sectional flow mediated dila-
tion of the brachial artery[16].
Independent predictors of mortality during the follow up
period were diabetes, AD and systolic blood pressure. Due
to their close interdependence, systolic blood pressure
and aortic distensibilty could not be independently
assessed. When a combined end point of death, non-fatal
myocardial infarction, cardiac revascularisation, amputa-
tion for peripheral vascular disease and cerebrovascular
event was used, only diabetes and AD or VAS were inde-
pendent predictors of events. Surprisingly, age was not a
predictor of outcome, suggesting that since age and AD
were closely correlated, vascular, rather than temporal,
aging is a more important determinant of survival. In
keeping with other studies, time on renal replacement
therapy was significantly longer in those patients who
died[4], but this was not independently associated with
outcome. Therefore in this patient group, AD was a pre-
dictor of mortality and/or vascular events independent of
age and dialysis vintage.
Haemodynamic factors which promote arterial remodel-
ling present in ESRD, although not specific to kidney dis-
ease, include age and blood pressure. Factors specific to
ESRD include arteriovenous shunts and chronic volume
overload[17]. Increased blood flow through a shunt pro-
motes arterial remodelling although may not lead to
detectible changes in measures of vascular function[18].
We could find no difference in AD or VAS in patients with
an arteriovenous shunt and those without. As novel
marker of increased CV risk, no data exist on the natural
history of progression of AD, or whether it can be
improved by therapeutic intervention. Our results suggest
that as there was no significant difference between those
CKD 5 patients on dialysis compared to pre-dialysis
patients, the major derangement in vascular function
occurs earlier during the progression of CKD. One
assumes that reduced AD is a consequence of arterial cal-
cification[19], although we cannot confirm this as CMR is
unable to display calcific lesions due to their absence of
water content.
A large number of studies have been performed to assess
the determinants of arterial stiffness in ESRD, and its rela-
tion to long term survival, using either incremental elastic
modulus, PWV or augmentation index as markers of arte-
rial stiffness. In keeping with our results, factors associated
with increased arterial stiffness include age, diabetes, and
systolic blood pressure (or pulse pressure) [20-22]. Other
factors associated with arterial stiffness include serum cal-
cium or the presence of inflammation[22]. Surprisingly,
these factors were not predictors of vascular function in
our study. Arterial stiffness has been repeatedly demon-
strated to be an independent predictor of all cause and
cardiovascular mortality in haemodialysis patients[3,4
,23].
Aside from the issue of use of brachial blood pressure to
calculate central haemodynamics, our study has some
other limitations. Although direct comparison between
CMR and calcification is not possible, CMR has emerged
as a technique for imaging atheroma. A direct comparison
between vascular function and dark blood imaging look-
ing at aortic wall thickness and atheroma would be of
interest but unfortunately was not performed. Measure-
ment of AD is still a relatively novel technique and its
widespread reproducibility is yet to be established. In
house blinded analysis has demonstrated an inter-
observer variability of 4.6%, although this needs to be
reproduced in other centres, particularly as there are
potential sources of error in both data acquisition and
analysis as well as in blood pressure measurements. As we
have previously used CMR with late gadolinium enhance-
ment (LGE) to analyse myocardial tissue composition in
ESRD[5], it would have been of interest to compare myo-
cardial tissue abnormalities with vascular function. How-
Table 4: Combined CV event and death survival
Univariate analysis Multivariate analysis
Variable HR (95.0% CI) p HR (95.0% CI) p
Diabetes 2.989 (1.276 7.004) 0.012 3.575 (1.669 7.655) 0.001
Log aortic distensibilty 0.052 (0.009 0.319) 0.001 0.066 (0.013 0.347) 0.001
Log aortic VAS 0.021 (0.002 0.206) 0.001 0.026 (0.004 0.175) <0.001
Duration RRT (days) 1.000 (1.000 1.000) 0.560
SBP (mmHg) 1.014 (0.995 1.032) 0.142
Age (years) 1.023 (0.984 1.062) 0.248
Gender (ref male) 0.827 (0.368 1.860) 0.646
Haemoglobin (g/dL) 0.958 (0.748 1.225) 0.731
Albumin (g/L) 0.984 (0.896 1.080) 0.728
Cox survival analysis for patient survival to either death or cardiovascular event. Because of their close correlation SBP aortic distensibilty and 
aortic VAS were entered separately into the model. Results for other variables are shown with systolic blood pressure in the model.Journal of Cardiovascular Magnetic Resonance 2008, 10:39 http://www.jcmr-online.com/content/10/1/39
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ever, as a link between gadolinium and nephrogenic
systemic fibrosis has emerged, this comparison is impos-
sible[24]. It is unfortunate that it was not possible to
acquire brachial blood pressure on every patient due to
some patients having multiple vascular procedures on
both upper limbs. Finally, CMR technique is relatively
expensive and time consuming to analyse. With future
development of automated analysis software, faster anal-
ysis of AD will be possible.
Conclusion
This study has demonstrated that vascular function can be
measured using CMR in ESRD. Increased aortic stiffness,
indicated by reduced AD and reduced VAS are associated
with risk factors for CV disease. Both AD and VAS were
independent predictors of combined vascular events and
mortality. AD predicted all cause mortality. Therefore,
CMR offers a novel non-invasive tool to assess vascular
function in patients ESRD. AD and VAS are potential tar-
gets for therapeutic intervention to reduce cardiovascular
risk in ESRD.
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